ESR1 and breast cancer: Thirdly, the native SOCE pathway was found to be mediated by Orai3 in estrogen receptor-positive breast cancer cells whereas the canonical STIM1/Orai1 pathway was shown to be used by estrogen receptor-negative breast cancer cells[33].